When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...

US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation ...

The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s ...

Chinese cybersecurity regulator details on the lenient certification method for cross-border data transfer; U.S. issues final ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

JPMorgan upgraded Wuxi Biologics (WXXWY) to Overweight from Neutral with a price target of HK$20, up from HK$13, citing expected order growth ...

Before Congress adjourned for Christmas, congressional leadership had set ambitious goals to counter the Chinese Communist ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...

A summary of recent health news includes Louisiana's first bird flu death, WuXi Biologics' sale of an Irish facility to Merck ...

WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company seeks ...